Tumor necrosis factor-alpha (TNF-α) levels in aqueous humor of primary open angle glaucoma

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 553-556

  Balaiya, Sankarathi ^a   Edwards, Jayson ^a   Tillis, Tina ^a   Khetpal, Vijay ^a   Chalam, Kakarla V ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Aqueous humor; Cytokine; POAG; TNF

Indexed keywords

BIOLOGICAL MARKER; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CATARACT EXTRACTION; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOASSAY; MALE; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PROTEIN DETERMINATION; TRABECULECTOMY; TREATMENT OUTCOME;

EID: 79956350256     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S19453     Document Type: Article

References (17)

1. Muñoz-Fernández MA, Fresno M. The role of tumor necrosis factor, interleukin 6, interferon-gamma, and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol. 1998;56(3):307-340.
2. Ertel W, Keel M, Bonaccio M, et al. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma. 1995;39(5):879-887.
3. Shohami E, Bass R, Wallach D, Yamin A, Gallily R. Inhibition of tumor necrosis factor alpha (TNF-α) activity in rat brain is associated with cerebroprotection after closed head injury. J Cerebr Blood Flow Metab. 1996;16(3):378-384.
4. Nakazawa T, Nakazawa C, Matsubara A, et al. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci. 2006;26(49):12633-12641.
5. Tezel G, Wax MB. Increased production of tumor necrosis factoralpha by glial cells exposed to stimulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci. 2000;20(23):8693-8700.
6. Yuan L, Neufeld AH. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia. 2000;32(1):42-50.
7. Tezel G, Li LY, Patil RV, Wax MB. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 2001;42(8):1787-1794.
8. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res. 2006;25(5):490-513.
9. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci. 2002;43(4):1077-1087.
10. Scalzo P, Kümmer A, Cardoso F, Teixeira AL. Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease. J Neuroimmunol. 2009 Nov 30;216(1-2):122-125.
11. Alvarez A, Cacabelos R, Sanpedro D, García-Fantini M, Aleixandre M. Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol Aging. 2007;28(4):533-536.
12. Tsukada N, Miyagi K, Matsuda M, Yanagisawa N, Yone K. Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. J Neurol Sci. 1991;104(2):230-234.
13. Ahmed F, Brown KM, Stephan DA, Morrison JC, Johnson EC, Tomarev SI. Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Invest Ophthalmol Vis Sci. 2004;45(4):1247-1258.
14. Hunot S, Hirsch EC. Neuroinflammatory processes in Parkinson's disease. Ann Neurol. 2003;53 Suppl 3:S49-S58; discussion S58-S60.
15. Heneka MT, O'Banion MK. Inflammatory processes in Alzheimer's disease. J Neuroimmunol. 2007;184(1-2):69-91.
16. Sawada H, Fukuchi T, Tanaka T, Abe H. Tumor necrosis factor-alpha concentrations in the aqueous humor of patients with glaucoma. Invest Ophthalmol Vis Sci. 2010;51(2):903-906.
17. Kuchtey J, Rezaei KA, Jaru-Ampornpan P, et al. Multiplex Cytokine Analysis Reveals Elevated Concentration of Interleukin-8 in Glaucomatous Aqueous Humor. Invest Ophthalmol Vis Sci. 2010;51(12):6441-6447.